4D Pharma PLC (LBPS)
US35085K1097 - ADR
| 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -53.96M | -25.96M | -24.07M | -23.69M | -20.45M | |||
| Depreciation Amortization | 980.00K | 1.20M | 1.28M | 1.21M | 982.00K | |||
| Change In Working Capital | -5.73M | -1.55M | 3.00M | -780.00K | -1.22M | |||
| Interest Paid | 490.00K | 170.00K | 180.00K | 1.00K | N/A | |||
| Taxes Paid | N/A | -1.70M | 780.00K | 1.17M | 1.01M | |||
| Other non cash items | 33.63M | 3.64M | -1.77M | 340.00K | 3.50M | |||
| OPERATING CASH FLOW | -25.08M | -22.67M | -21.56M | -22.94M | -17.19M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -200.00K | -180.00K | -590.00K | -540.00K | -2.08M | |||
| Other Investing Activity | N/A | 0.00 | 10.22M | 27.68M | 2.49M | |||
| INVESTING CASH FLOW | -200.00K | -180.00K | 9.62M | 27.14M | 408.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 8.81M | -190.00K | -200.00K | -10.00K | -14.00K | |||
| Stock Issued/Repurchased | 27.90M | 29.74M | 0.00 | N/A | N/A | |||
| Other Financing Activity | -4.71M | -1.76M | -90.00K | 0.00 | N/A | |||
| FINANCING CASH FLOW | 32.01M | 27.79M | -280.00K | -10.00K | -14.00K | |||
| CHANGE IN CASH | 6.73M | 4.94M | -12.22M | 4.19M | -16.80M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -25.08M | -22.67M | -21.56M | -22.94M | -17.19M | |||
| Capital Expenditure | -200.00K | -180.00K | -590.00K | -540.00K | -2.08M | |||
| FREE CASH FLOW | -25.28M | -22.85M | -22.15M | -23.48M | -19.27M | |||
All data in GBP